Jerzy Gumulka
Director/Board Member presso CNS PHARMACEUTICALS, INC.
Patrimonio netto: 15 568 $ in data 31/03/2024
Profilo
Jerzy Gumulka is an Independent Director at CNS Pharmaceuticals, Inc. He previously worked as a Director at Moleculin LLC from 2010 to 2016.
Prior to that, he held the position of Technical Director at Kraton Polymers Do Brasil Industria e Comercio de Produtos from 2001 to 2015, and as a Technology Manager at Kraton Polymers U.S.
LLC from 2001 to 2016.
Dr. Gumulka obtained a doctorate degree from the University of Warsaw.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2024 | 43 006 ( 0.51% ) | 15 568 $ | 31/03/2024 |
Posizioni attive di Jerzy Gumulka
| Società | Posizione | Inizio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2017 |
Precedenti posizioni note di Jerzy Gumulka
| Società | Posizione | Fine |
|---|---|---|
Kraton Polymers U.S. LLC
 Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01/06/2016 |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Director/Board Member | 01/01/2016 |
Kraton Polymers do Brasil SA
 Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Formazione di Jerzy Gumulka
| University of Warsaw | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Health Technology |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Producer Manufacturing |
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Process Industries |
- Borsa valori
- Insiders
- Jerzy Gumulka
